Nucleic Acid Targeted Therapy: G4 Oligonucleotides Downregulate HRAS in Bladder Cancer Cells through a Decoy Mechanism. ACS Med. Chem. Lett., (2015), 6 (12), 1179-1183
ACS Med. Chem. Lett. • 2015
Publication Information
Authors
Giulia Miglietta; Alaa S. Gouda; Susanna Cogoi; Erik B. Pedersen; Luigi E. Xodo.
Keywords
HRAS, G4-oligonucleotides, anthraquinone insertions, T24 bladder cancer cells, decoy mechanism
Journal
ACS Med. Chem. Lett.
Publisher
American Chemical Society
Volume
6
Issue
12
Pages
1179-1183
publication.type
International
Paper Link
Open Link
Supplementary Materials
Not Available
Abstract
In a previous study we have demonstrated that two neighboring G-quadruplexes, hras-1 and hras-2, located immediately 16 upstream of the major transcription start site of HRAS, bind MAZ, a nuclear factor that activates transcription (doi: 17 10.1093/nar/gku574). For the present study we have designed G4 oligonucleotides with anthraquinone insertions and locked nucleic 18 acids (LNA) modifications mimicking quadruplex hras-1. Luciferase, qRT-PCR and Western blot data demonstrate that these con19 structs efficiently down regulate HRAS in cancer cells. The inhibitory efficiency of the G4 oligonucleotides correlates with their 20 nuclease resistance in the cell environment. By chromatin immunoprecipitation we show that the association of MAZ to the HRAS 21 promoter is strongly attenuated by the designed G4 oligonucleotides, thus suggesting that these constructs behave with a decoy mechanism
Staff Members - Benha University